Modulation of WIN55,212-2 state-dependent memory by α2- adrenergic receptors of the dorsal hippocampus

Archives of Iranian Medicine

Volumn 14, Issue 6, 2011, Pages 389-395

  Piri, Morteza ^a   Zarrindast, Mohammad Reza ^b,c,d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^d INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clonidine; Rat; State dependent memory; WIN55,212 2; Yohimbine

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; YOHIMBINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPAL CA1 REGION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; NEUROMODULATION; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN FUNCTION; RAT; STATE DEPENDENT LEARNING; TASK PERFORMANCE; TRAINING;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AMNESIA; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZOXAZINES; CA1 REGION, HIPPOCAMPAL; CLONIDINE; MALE; MEMORY; MORPHOLINES; NAPHTHALENES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, CANNABINOID; STATISTICS, NONPARAMETRIC; YOHIMBINE;

EID: 80355127117     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Fazli-Tabaei S, Yahyavi SH, Zarrindast MR. Effects of lithium carbonate on apomorphine-induced snifling behaviour in rats. Pharmacol Toxicol. 2002; 91: 135-139.
2. Clarke JR, Rossato JI, Monteiro S, Bevilaqua LR, Izquierdo I, Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition longterm memory. Neurobiol Learn Mem. 2008; 90: 374-381.
3. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science. 2002; 296: 678-682.
4. Davies SN, Pertwee RG, Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology. 2002; 42: 993-1007.
5. Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl). 1995; 119: 282-290.
6. Nasehi M, Piri M, Jamali-Raeufy N, Zarrindast MR. Influence of intracerebral administration of NO agents in dorsal hippocampus (CA1) on cannabinoid state-dependent memory in the step-down passive avoidance test. Physiol Behav. 2010; 100: 297-304.
7. Zarrindast MR, Dorrani M, Lachinani R, Rezayof A. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice. Neurosci Res. 2010; 67: 25-32.
8. Lowe G. State-dependent learning effects with a combination of alcohol and nicotine. Psychopharmacology (Berl). 1986; 89: 105-107.
9. Shulz DE, Sosnik R, Ego V, Haidarliu S, Ahissar E. A neuronal analogue of state-dependent learning. Nature. 2000; 403: 549-553.
10. Izquierdo I, Dias RD. Memory as a state dependent phenomenon: role of ACTH and epinephrine. Behav Neural Biol. 1983; 38: 144-149.
11. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993; 365: 61-65.
12. Al-Hayani A, Davies SN. Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent. Eur J Pharmacol. 2002; 442: 47-54.
13. Egashira N, Mishima K, Katsurabayashi S, Yoshitake T, Matsumoto Y, Ishida J, et al. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol. 2002; 445: 221-229.
14. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA. 2005; 102: 18620-18625.
15. Hungund BL, Basavarajappa BS, Vadasz C, Kunos G, Rodriguez de Fonseca F, Colombo G, et al. Ethanol, endocannabinoids and the cannabinoidergic signaling system. Alcohol Clin Exp Res. 2002; 26: 565-574.
16. Shen M, Piser TM, Seybold VS, Thayer SA. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci. 1996; 16: 4322-4334.
17. Gifford AN, Tang Y, Gatley SJ, Volkow ND, Lan R, Makriyannis A. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci Lett. 1997; 238: 84-86.
18. Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci. 2001; 22: 565-572.
19. Clayton EC, Williams CL. Adrenergic activation of the nucleus tractus solitarius potentiates amygdala norepinephrine release and enhances retention performance in emotionally arousing and spatial memory tasks. Behav Brain Res. 2000; 112: 151-158.
20. Hat-eld T, McGaugh JL. Norepinephrine infused into the basolateral amygdala posttraining enhances retention in a spatial water maze task. Neurobiol Learn Mem. 1999; 71: 232-239.
21. Izquierdo LA, Vianna M, Barros DM, Mello e Souza T, Ardenghi P, Sant'Anna MK, et al. Short- and long-term memory are differentially affected by metabolic inhibitors given into hippocampus and entorhinal cortex. Neurobiol Learn Mem. 2000; 73: 141-149.
22. Sirvio J, MacDonald E. Central alpha1-adrenoceptors: their role in the modulation of attention and memory formation. Pharmacol Ther. 1999; 83: 49-65.
23. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev. 2003; 42: 33-84.
24. Stuchlik A, Petrasek T, Vales K. Effect of alpha(1)-adrenergic antagonist prazosin on behavioral alterations induced by MK-801 in a spatial memory task in Long Evans rats. Physiol Res. 2008: 58: 733-740.
25. Arnsten AF, Berridge C, Segal DS. Stress produces opioid-like effects on investigatory behavior. Pharmacol Biochem Behav. 1985; 22: 803-809.
26. Arnsten AF, Cai JX, Goldman-Rakic PS. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for alpha-2 receptor subtypes. J Neurosci. 1988; 8: 4287-4298.
27. Cai JX, Ma YY, Xu L, Hu XT. Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res. 1993; 614: 191-196.
28. Jin XC, Ma CL, Li BM. The alpha (2A)-adrenoceptor agonist guanfacine improves spatial learning but not fear conditioning in rats. Sheng Li Xue Bao. 2007; 59: 739-744.
29. Arnsten AF, Steere JC, Jentsch DJ, Li BM. Noradrenergic influences on prefrontal cortical cognitive function: Opposing actions at postjunctional alpha 1 versus alpha 2-adrenergic receptors. Adv Pharmacol. 1998; 42: 764-767.
30. Franowicz JS, Arnsten AF. The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacology (Berl). 1998; 136: 8-14.
31. Camacho F, Smith CP, Vargas HM, Winslow JT. Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat. Psychopharmacology (Berl). 1996; 124: 347-54.
32. Lapiz MD, Morilak DA. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience. 2006; 137: 1039-1049.
33. Azami NS, Piri M, Oryan S, Jahanshahi M, Babapour V, Zarrindast MR. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol Learn Mem. 2010; 93: 455-462.
34. Mair RG, McEntee WJ. Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology (Berl). 1986; 88: 374-380.
35. Fields RB, Van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, et al. Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary endings. Schizophr Res. 1988; 1: 417-423.
36. Jakala P, Riekkinen M, Sirvio J, Koivisto E, Kejonen K, Vanhanen M, et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology. 1999; 20: 460-470.
37. Jakala P, Sirvio J, Riekkinen M, Koivisto E, Kejonen K, Vanhanen M, et al. Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology. 1999; 20: 119-130.
38. Izquierdo I, Medina JH. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem. 1995; 63: 19-32.
39. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993; 361: 31-39.
40. Singh PP, Das PK. Role of catecholamines in the hypothermic activity of cannabis in albino rats. Psychopharmacology (Berl). 1976; 50: 199-204.
41. Lichtman AH, Martin BR. Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism. Brain Res. 1991; 559: 309-314.
42. Bonnin A, de Miguel R, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ. The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 1995; 56: 2177-2184.
43. Hernandez-Tristan R, Arevalo C, Canals S, Leret ML. The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. J Physiol Biochem. 2000; 56: 17-24.
44. Schlicker E, Timm J, Zentner J, Gothert M. Cannabinoid CB1 receptormediated inhibition of noradrenaline release in the human and guineapig hippocampus. Naunyn Schmiedebergs Arch Pharmacol. 1997; 356: 583-589.
45. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press; 2007.
46. Rubin MA, Stiegemeier JA, Volkweis MA, Oliveira DM, Fenili AC, Boemo RL, et al. Intra-amygdala spermidine administration improves inhibitory avoidance performance in rats. Eur J Pharmacol. 2001; 423: 35-39.
47. Walz R, Roesler R, Quevedo J, Rockenbach IC, Amaral OB, Vianna MR, et al. Dose-dependent impairment of inhibitory avoidance retention in rats by immediate post-training infusion of a mitogen-activated protein kinase kinase inhibitor into cortical structures. Behav Brain Res. 1999; 105: 219-223.
48. Izquierdo I, Schroder N, Netto CA, Medina JH. Novelty causes timedependent retrograde amnesia for one-trial avoidance in rats through NMDA receptor- and CaMKII-dependent mechanisms in the hippocampus. Eur J Neurosci. 1999; 11: 3323-3328.
49. Zarrindast MR, Noorbakhshnia M, Motamedi F, Haeri-Rohani A, Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology. 2006; 76: 93-100.
50. Nasehi M, Sahebgharani M, Haeri-Rohani A, Zarrindast MR. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-day apomorphine-treated rats. Neurobiol Learn Mem. 2009; 92: 391-399.
51. Kameyama T, Nabeshima T, Kozawa T. Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models. J Pharmacol Methods. 1986; 16: 39-52.
52. Hampson RE, Deadwyler SA. Cannabinoids, hippocampal function and memory. Life Sci. 1999; 65: 715-723.
53. Zarrindast MR, Kangarlu-Haghighi K, Khalilzadeh A, Fazli-Tabaei S. Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Behav Pharmacol. 2006; 17: 231-237.
54. Rassouli Y, Rezayof A, Zarrindast MR. Role of the central amygdala GABA-A receptors in morphine state-dependent memory. Life Sci. 2010; 86: 887-893.
55. Jafari-Sabet M, Zarrindast MR, Rezayat M, Rezayof A, Djahanguiri B. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice. Life Sci. 2005; 78: 157-163.
56. Rezayof A, Motevasseli T, Rassouli Y, Zarrindast MR. Dorsal hippocampal dopamine receptors are involved in mediating ethanol statedependent memory. Life Sci. 2007; 80: 285-292.
57. Zarrindast MR, Khalilzadeh A, Malekmohammadi N, Fazli-Tabaei S. Influence of morphine- or apomorphine-induced sensitization on histamine state-dependent learning in the step-down passive avoidance test. Behav Brain Res. 2006; 171: 50-55.
58. Zarrindast MR, Fazli-Tabaei S, Khalilzadeh A, Farahmanfar M, Yahyavi SH. Cross state-dependent retrieval between histamine and lithium. Physiol Behav. 2005; 86: 154-163.
59. Colpaert FC. Amnesic trace locked into the benzodiazepine state of memory. Psychopharmacology (Berl). 1990; 102: 28-36.
60. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999; 283: 401-404.
61. Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci. 2004; 74: 1317-1324.
62. Homayoun H, Khavandgar S, Zarrindast MR. Morphine state-dependent learning: interactions with alpha2-adrenoceptors and acute stress. Behav Pharmacol. 2003; 14: 41-48.
63. Arnsten AF, Contant TA. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology (Berl). 1992; 108: 159-169.
64. Introini-Collison IB, Castellano C, McGaugh JL. Interaction of GABAergic and beta-noradrenergic drugs in the regulation of memory storage. Behav Neural Biol. 1994; 61: 150-155.
65. Scheiderer CL, Dobrunz LE, McMahon LL. Novel form of long-term synaptic depression in rat hippocampus induced by activation of alpha 1 adrenergic receptors. J Neurophysiol. 2004; 91: 1071-1077.
66. Chen MF, Chiu TH, Lee EH. Noradrenergic mediation of the memoryenhancing effect of corticotropin-releasing factor in the locus coeruleus of rats. Psychoneuroendocrinology. 1992; 17: 113-124.
67. Zarrindast MR, Khodjastehfar E, Oryan S, Torkaman-Boutorabi A. Baclofen- mpairment of memory retention in rats: possible interaction with adrenoceptor mechanism(s). Eur J Pharmacol. 2001; 411: 283-288.
68. Dennis T, L'Heureux R, Carter C, Scatton B. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther. 1987; 241: 642-649.
69. Kamisaki Y, Hamahashi T, Hamada T, Maeda K, Itoh T. Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions. Eur J Pharmacol. 1992; 217: 57-63.
70. Pudovkina OL, Westerink BH. Functional role of alpha1-adrenoceptors in the locus coeruleus: a microdialysis study. Brain Res. 2005; 1061: 50-56.
71. Tellez S, Colpaert F, Marien M. Acetylcholine release in the rat prefrontal cortex in vivo: Modulation by alpha 2-adrenoceptor agonists and antagonists. J Neurochem. 1997; 68: 778-785.
72. Tellez S, Colpaert F, Marien M. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience. 1999; 89: 1041-1050.
73. Arnsten AF, Leslie FM. Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype. Neuropharmacology. 1991; 30: 1279-1289.